Your browser doesn't support javascript.
Clinic- and Community-Based SARS-CoV-2 Testing Among People Experiencing Homelessness in the United States, March-November 2020.
Berner, Lauryn; Meehan, Ashley; Kenkel, Joseph; Montgomery, Martha; Fields, Victoria; Henry, Ankita; Boyer, Alaina; Mosites, Emily; Vickery, Katherine Diaz.
  • Berner L; National Health Care for the Homeless Council, Nashville, TN, USA.
  • Meehan A; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kenkel J; National Health Care for the Homeless Council, Nashville, TN, USA.
  • Montgomery M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Fields V; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Henry A; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Boyer A; National Health Care for the Homeless Council, Nashville, TN, USA.
  • Mosites E; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Vickery KD; Hennepin Healthcare, Minneapolis, MN, USA.
Public Health Rep ; 137(4): 764-773, 2022.
Article in English | MEDLINE | ID: covidwho-1784976
ABSTRACT

OBJECTIVE:

SARS-CoV-2 testing is a critical component of preventing the spread of COVID-19. In the United States, people experiencing homelessness (PEH) have accessed testing at health clinics, such as those provided through Health Care for the Homeless (HCH) clinics or through community-based testing events at homeless service sites or encampments. We describe data on SARS-CoV-2 testing among PEH in US clinic- and community-based settings from March through November 2020.

METHODS:

We conducted a descriptive analysis of data from HCH clinics and community testing events. We used a standardized survey to request data from HCH clinics. We developed and made publicly available an online data entry portal to collect data from community-based organizations that provided testing for PEH. We assessed positivity rates across clinics and community service sites serving PEH and used generalized linear mixed models to account for clustering.

RESULTS:

Thirty-seven HCH clinics reported providing 280 410 tests; 3.2% (n = 8880) had positive results (range, 1.6%-4.9%). By race, positivity rates were highest among people who identified as >1 race (11.6%; P < .001). During the reporting period, 22 states reported 287 community testing events and 14 116 tests; 7.1% (n = 1004) had positive results. Among facility types, day shelters (380 of 2697; 14.1%) and inpatient drug/alcohol rehabilitation facilities (32 of 251; 12.7%) reported the highest positivity rates.

CONCLUSIONS:

While HCH clinic data provided results for a larger number of patients, community-based testing data showed higher positivity rates. Clinic data demonstrated racial disparities in positivity. Community-based testing data provided information about SARS-CoV-2 transmission settings. Although these data provide information about testing, standard surveillance systems are needed to better understand the incidence of disease among PEH.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ill-Housed Persons / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: Public Health Rep Year: 2022 Document Type: Article Affiliation country: 00333549221086514

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ill-Housed Persons / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: Public Health Rep Year: 2022 Document Type: Article Affiliation country: 00333549221086514